Fingolimod effects on left ventricular function in multiple sclerosis

Conclusion:
Fingolimod significantly reduces left ventricular systolic function in MS patients. This effect has no clinical consequences in subjects without previous cardiac disorders, but suggests that more caution is required in patients with current or previous heart failure.

Source: Multiple Sclerosis - February 1, 2016 Category: Neurology Authors: Racca, V., Di Rienzo, M., Cavarretta, R., Toccafondi, A., Vaini, E., Ferratini, M., Rovaris, M. Tags: Original Research Papers Source Type: research